Myosin Therapeutics Secures Funding for Innovative Cancer Trial in Florida Myosin Therapeutics has received a $2 million grant from the Florida Department of Health to support the STAR-GBM clinical trial, advancing innovative cancer treatments.

Myosin Therapeutics Secures Funding for Innovative Cancer Trial in Florida #United_States #Jupiter #Myosin_Therapeutics #Cancer_Innovation #STAR-GBM

Starget Pharma Secures $18 Million Series A Funding to Enhance Cancer Therapy Development Starget Pharma Inc. has closed an $18 million Series A funding round and partnered with CMIT to advance innovative cancer therapies using AI technology.

Starget Pharma Secures $18 Million Series A Funding to Enhance Cancer Therapy Development #United_States #Shreveport #Cancer_Innovation #Starget_Pharma #CMIT

Hengrui Pharma's Groundbreaking Contributions at 2025 ASCO Conference: A Showcase of Cancer Innovations At the 2025 ASCO Annual Meeting, Hengrui Pharma presented groundbreaking research findings that assess their innovative cancer treatments' efficacy in various oncology fields.

Hengrui Pharma's Groundbreaking Contributions at 2025 ASCO Conference: A Showcase of Cancer Innovations #China #Shanghai #Hengrui_Pharma #ASCO_2025 #Cancer_Innovation